Comparison of SARS-CoV-2 Antibody Response After 2-Dose mRNA-1273 vs BNT162b2 Vaccines in Incrementally Immunosuppressed Patients
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.11897
Abstract: This cohort study compares the antispike antibody titers of the mRNA-1273 and BNT162b2 vaccines for SARS-CoV-2 in incrementally immunosuppressed patients. read more here.
Keywords: incrementally immunosuppressed; mrna 1273; bnt162b2 vaccines; immunosuppressed patients ... See more keywords
Induction of SARS-CoV-2 neutralizing antibodies by CoronaVac and BNT162b2 vaccines in naïve and previously infected individuals
Sign Up to like & getrecommendations! Published in 2022 at "EBioMedicine"
DOI: 10.1016/j.ebiom.2022.103972
Abstract: Background A major challenge of the SARS-CoV-2 pandemic is to better define “protective thresholds” to guide the global response. We aimed to characterize the longitudinal dynamics of the antibody responses in naturally infected individuals in… read more here.
Keywords: sars cov; coronavac bnt162b2; antibody; infected individuals ... See more keywords
Neutralizing antibody titers elicited by CoronaVac and BNT162b2 vaccines in health care workers with and without prior SARS-CoV-2 infection
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Travel Medicine"
DOI: 10.1093/jtm/taac010
Abstract: We report neutralizing antibody titers (NAbTs) elicited by CoronaVac and BNT162b2 vaccines in healthcare workers with and without prior SARS-CoV-2 infection using both a pseudotype-based assay and a commercial kit. NAbTs were higher for the… read more here.
Keywords: coronavac bnt162b2; bnt162b2 vaccines; antibody titers; elicited coronavac ... See more keywords